|
|
|
|
Vol. 302, Issue 1, 397-405, July 2002
Departments of Pharmacology (J.L., T.J.-F.L.) and Neurology (M.S.E.), Southern Illinois University School of Medicine, Springfield, Illinois
| |
Abstract |
|---|
|
|
|---|
Results of previous pharmacological studies suggested that presynaptic
muscarinic M2 receptors on cerebral perivascular nitric oxidergic (nitrergic) nerves mediated inhibition of nitric oxide release from these nerves. The inhibition was thought to be primarily attributable to a decreased Ca2+ influx through N-type
Ca2+ channels on nitrergic nerves, but direct evidence
supporting this hypothesis was not presented. In the present study, we
used cultured rat sphenopalatine ganglion (SPG), a major source of nitrergic nerves to cerebral blood vessels, to investigate the role of
muscarinic M2 receptors in modulating voltage-dependent Ca2+ channels. SPG neuronal soma and dendrites were
immunoreactive for both N-type Ca2+ channels and muscarinic
M2 receptors, indicating that muscarinic M2
receptors were colocalized with N-type Ca2+ channels. Using
the whole-cell voltage-clamp technique, we found that voltage-dependent
Ca2+ currents in cultured SPG were largely blocked by
-conotoxin, an N-type calcium channel antagonist, but were not
affected by nifedipine, an L-type calcium antagonist. The
Ca2+ current was inhibited by acetylcholine (ACh) and
arecaidine but-2-ynyl ester tosylate (ABET), a preferential muscarinic
M2-receptor agonist, in a concentration-dependent manner.
The inhibition was reversed by atropine and methoctramine (a muscarinic
M2-receptor antagonist), but was not affected by muscarinic
M1-, M3-, or M4-receptor
antagonists. Consistent with this, preferential muscarinic
M1-receptor agonists McN-A-343 and oxotremorine did not
affect the Ca2+ current. Furthermore, pretreatment with
pertussis toxin and guanosine 5'-O-(3-thio)triphosphate
prevented ACh and ABET inhibition of Ca2+ currents. These
results are consistent with pharmacological findings in the pig basilar
arteries and provide direct evidence supporting our hypothesis that
M2-receptor-mediated inhibition of cerebral nitrergic
neurogenic vasodilation is due to a Gi-protein-mediated suppression of Ca2+ influx via voltage-dependent N-type
Ca2+ channels on perivascular nerves.
| |
Introduction |
|---|
|
|
|---|
The
large cerebral arteries of several species such as dog, pig, cow, and
monkey have been shown to receive dense cholinergic innervation (Lee,
1994
). At one time, it was assumed that ACh acted as the transmitter
for cerebral neurogenic vasodilation. This assumption was questioned
when the vasodilation in isolated cat cerebral arterial rings induced
by electrical stimulation of the perivascular nerves was not blocked by
atropine (Lee et al., 1975
; Lee, 1980
). It is now clear that nitric
oxide (NO), which is released from cholinergic-nitric oxidergic nerves
(Kimura et al., 1997
), is the major transmitter mediating cerebral
neurogenic vasodilation (Toda and Okamura, 1990
; Lee and Sarwinski,
1991
; Gonzalez et al., 1992
). ACh released from these nerves has been suggested to act as a presynaptic modulator (Lee, 1986
; Ayajiki et al.,
1993
) or transmitter (Liu and Lee, 1999
) in inhibiting NO release. Our
previous studies using in vitro tissue bath techniques demonstrated
that ACh inhibition of NO-mediated neurogenic vasodilation in porcine
cerebral arteries was mediated by activation of presynaptic muscarinic
M2 receptors located on perivascular nitrergic
nerves, possibly resulting in suppression of voltage-dependent
Ca2+ channels on those nerves (Liu and Lee,
1999
). Because the Ca2+ influx from the
voltage-dependent Ca2+ channels is crucial in
activating the Ca2+-dependent NO synthase (NOS)
in neurons (Boeckxstaens et al., 1993
), suppression of these channels
leads to a decreased NO formation and release from these nerves. Direct
evidence for inhibition of voltage-dependent Ca2+
channel by activation of muscarinic receptors in the cerebral perivascular nerves, however, has not been presented.
Although inhibition of voltage-dependent Ca2+
channels by muscarinic agonists has been reported in several types of
neurons in the central and peripheral nervous systems (Mochida and
Kobayashi, 1986
; Wanke et al., 1987
; Beech et al., 1992
; Bernheim et
al., 1992
; Allen and Brown, 1993
; Cuevas and Adams, 1997
; Jeong and Wurster, 1997
), direct demonstration of a muscarinic effect on Ca2+ channels in the perivascular nerves is
technically formidable because of difficulty in using patch-clamp
techniques on these nerves. Because the major portion of cerebral
perivascular nitrergic nerves originates in the sphenopalatine ganglion
(SPG) in many species including cat, pig, and rat (Hara et al., 1989
;
Suzuki et al., 1990
; Nozaki et al., 1993
; Suzuki and Hardebo, 1993
;
Minami et al., 1994
; Kadota et al., 1996
; Kimura et al., 1997
; Yu et al., 1997
), the present study was designed to determine the role of
muscarinic receptors in inhibiting voltage-dependent
Ca2+ channels in the cultured adult rat SPG by
using whole-cell patch-clamp recording. We already have shown that
cultured adult rat SPG neurons (both soma and dendrites) are similar to
cerebral perivascular nerves of the pig in their immunohistochemical,
pharmacological, and electrophysiological characteristics (Liu et al.,
2000
). Specifically, both soma and dendrites of the cultured rat SPG
contain N-type Ca2+ channels, which are the
dominant voltage-dependent Ca2+ channels in
regulating Ca2+ influx during membrane
depolarization (Liu et al., 2000
).
For comparison, the in vitro tissue bath technique was used also to
continue examination of presynaptic muscarinic receptors in modulating
NO-mediated neurogenic vasodilation in porcine cerebral arterial rings
(Liu and Lee, 1999
).
| |
Materials and Methods |
|---|
|
|
|---|
Isolation and Culture of Rat SPG Neurons.
These were carried
out according to methods in our previous report (Liu et al., 2000
).
Sprague-Dawley rats (3 to 16 weeks old) were anesthetized with sodium
pentobarbital (50 mg/kg, i.p.). The sphenopalatine ganglia of both
sides were dissected (Spencer et al., 1990
; Liu et al., 2000
) and were
placed in cold Hibernate A (Invitrogen, Carlsbad, CA) solution. Ganglia
were cut into smaller pieces; transferred to
Mg2+- and Ca2+-free Hanks'
balanced salt solution (Invitrogen) containing papain (2 U/ml;
Sigma-Aldrich, St. Louis, MO), collagenase D (0.6 mg/ml; Roche Applied
Science, Indianapolis, IN), and Dispase (2.4 mg/ml, Invitrogen); and
then incubated for 40 min at 37°C. Cells were released by gentle
trituration at the end of the incubation. The cell suspension was
centrifuged at 300g for 5 min. The pellet was gently
resuspended in neurobasal culture medium (Invitrogen), containing B27
(1:50 dilution, Invitrogen), 0.5 mM L-glutamine, 25 µM L-glutamate and 50 ng/ml nerve growth
factor (Alomome Laboratories Ltd, Jerusalem, Israel) (Brewer et
al., 1993
; Liu et al., 2000
). All medium and Hanks' balanced salt
solution contained 100 U/ml penicillin and 100 U/ml streptomycin
(Invitrogen). The cell suspension was plated into a 24-well culture
plate with a poly-D-lysine coated (50 µg/ml,
Sigma-Aldrich) glass coverslip (12-mm diameter; Carolina Biological
Supply Co., Burlington, NC) in each well and incubated with air
containing 5% CO2 at 37°C. The growth medium
was changed every 6 days.
Immunocytochemistry.
SPG neurons cultured for 1 to 3 weeks
were fixed in 4% paraformaldehyde for 20 to 60 min at room temperature
or overnight at 4°C. After rinsing three times with PBS (pH 7.4),
cells were permeabilized and nonspecific sites were blocked with 5%
normal goat serum in 0.2% Triton X-100 PBS for 1 h at room
temperature. After rinsing once, the cells were incubated
simultaneously with anti-M2 muscarinic receptor
antibody and anti-
1b-subunit of voltage-gated Ca2+ channel (N-type Ca2+
channel) antibody at room temperature overnight. The
anti-M2-receptor antibody was a monoclonal
antibody raised from rat (Chemicon; 1:100 dilution). The
anti-
1b-subunit of voltage-gated
Ca2+ channel antibody was a polyclonal antibody
raised from rabbit (1: 200 dilution; Alomone Laboratories). The
antibodies were diluted in 0.05% Triton X-100/PBS/1.5% NGS. After
incubation with the primary antibodies, the cells were rinsed with PBS
three times before incubating with secondary antibodies. The secondary
antibodies were fluorescein-conjugated anti-rabbit IgG (1:40 dilution;
Vector Laboratories, Burlingame, CA) or rhodamine-conjugated anti-rat IgG (1:40 dilution; Jackson Immunoresearch Laboratories, Inc., West
Grove, PA). After 1-h incubation with second antibodies at room
temperature, cells were rinsed with PBS (pH 8.2) three times and
mounted in Vectashield mounting medium (Vector Laboratories). The
stained cells were observed and photographed first under a fluorescence
microscope (BX50 microscope; Olympus, Tokyo, Japan) fitted with a
fluorescein filter. Without changing field, cells were photographed for
the second time using a rhodamine filter. Negative controls were
obtained following the same incubation procedure with neutralized serum
by corresponding antigen (Liu et al., 2000
).
Electrophysiology.
Electrophysiological study using
patch-clamp recording was carried out as described previously (Liu et
al., 2000
). In brief, a glass coverslip containing cultured neurons was
transferred from the growth medium to a 35-mm plastic Petri dish
containing the extracellular recording solution (described below; Liu
et al., 2000
) on a phase-contract microscope (Olympus IMT2). The calcium currents were recorded in the whole-cell configuration of the
patch-clamp technique (Hamill et al., 1981
; Liu et al., 2000
) at room
temperature. Patch electrodes were pulled from 1.5-mm outer diameter
with 1.0-mm inner diameter capillary glass (World Precision Instruments
PG52151-4), and the tips were then fire-polished. After filling with
intracellular solution (described below; Liu et al., 2000
), electrode
impedance in the extracellular recording solution was 3 to 4 megohms.
This component of the series resistance was fully compensated using the
bridge balance control of the Axoclamp 2B (Axon Instruments) used for
recording. The electrode tip potential was also subtracted while in
bridge mode. Tight seals of at least 2 gigaohms, but usually 5 to 10 gigaohms were obtained by light suction. Electrode series resistance
increased to 6 to 8 megohms after entry into whole-cell mode but was
not further compensated. Voltage protocol generation and data
acquisition were performed using pClamp software (Axon Instruments,
Foster City, CA) and a digital data acquisition system (Digidata 1200). To evoke calcium currents, test pulses to 0 mV for 100 ms were applied
every 15 s from a
70 mV holding potential in the absence or
presence of drugs. The current traces were low-pass filtered at 3 kHz
and digitized at 20 kHz. The resistive and capacitative components of
the leak current were subtracted using a P/4 procedure (Armstrong and
Bezanilla, 1974
; Evans et al., 1998
). Data were stored in a computer
hard drive for later analysis. The concentration that produced 50%
inhibition of maximal relaxation or peak Ca2+
currents (EC50) were calculated for each
preparation. From these values, the geometric means for
EC50 with 95% confidence intervals were
calculated (Fleming et al., 1972
).
In Vitro Tissue Bath Study on Neurogenic Vasodilation in Porcine
Basilar Arterial Rings.
Fresh heads of adult pigs of either sex
were collected from a local slaughterhouse. The entire brain was
removed and placed in a Krebs-bicarbonate solution equilibrated with
95% O2-5% CO2 at room
temperature. Basilar arteries were dissected and cleaned of surrounding
tissue under a dissecting microscope. The ring segment (4 mm long),
with endothelium mechanically denuded (Lee, 1982
), was cannulated with
a stainless steel rod (30-gauge hemispherical section) and a short
piece of platinum wire and mounted in a tissue bath containing 6 ml of
Krebs-bicarbonate solution equilibrated with 95%
O2-5% CO2 at 37°C.
Tissues were equilibrated in the Krebs-bicarbonate solution for 30 min
and then were mechanically stretched to a resting tension of
0.75g for another 30 min. U-46619 (0.1-1 µM) was then
applied to induce an active muscle tone of about 0.75g. Tissues were electrically and transmurally stimulated with a pair of
platinum electrodes through which 100 biphasic square-wave pulses of
0.6 ms in duration and 200 mA in intensity were applied at various
frequencies (Lee, 1982
). The neurogenic origin of this TNS-induced
response was verified by its complete blockade by 1 µM TTX.
Papaverine (300 µM) was applied to each tissue at the end of the
experiment to induce maximal relaxation. The magnitude of a vasodilator
response was expressed as a percentage of the maximal response induced
by papaverine (Lee, 1982
).
Solutions, Drugs Used, and Statistical Methods. The Krebs-bicarbonate solution for tissue bath contained 122.0 mM NaCl, 5.2 mM KCl, 1.33 mM CaCl2, 1.2 mM MgSO4, 25.0 mM NaCO3, 0.03 mM disodium EDTA, 0.01 mM L-ascorbic acid, and 11.0 mM glucose (pH 7.4). Extracellular solution for Ca2+ current recording contained 130 mM NaCl, 3 mM KCl, 1 mM MgCl2, 5.0 mM barium chloride (or 2.5 mM CaCl2), 25 mM dextrose, and 10 mM MOPS (pH 7.25). Intracellular solution for Ca2+ current recording contained 140 mM cesium methane sulfonate, 1 mM MgCl2, 5 mM EGTA, 10 mM HEPES, 2 mM MgATP, and Na3GTP (pH 7.25).
The following drugs were used: acetylcholine chloride (ACh), atropine, nitro-L-arginine (L-NNA), L-arginine, tetrodotoxin (TTX), U-46619, 8-bromoadenosine 3',5'-cyclic monophosphate (8-bromo-cAMP), nitroblue tetrazolium, and guanosine 5'-O-(3-thio)triphosphate (GTP
S) (all from
Sigma-Aldrich); physostigmine, tropicamide, 4-DAMP mustard HCl,
methoctramine HCl, McN-A-343, oxotremorine M, pirenzepine,
-conotoxin GVIA, and pertussis toxin (all from Sigma/RBI, Natick,
MA); arecaidine but-2-ynyl ester tosylate (ABET) and MR16728
hydrochloride (Tocris Cookson, St. Louis, MO).
The data obtained from the tissue bath study were computed as
means ± S.E.M. and were evaluated by Student's t test
for paired samples and analysis of variance for multigroup comparisons.
The data obtained from electrophysiological studies were computed as
means ± S.D. and were evaluated by Student's t test.
| |
Results |
|---|
|
|
|---|
Effect of ACh on Ca2+ Channel Currents in Cultured Rat
SPG Neurons.
ACh (0.1-1 µM) significantly inhibited the peak
Ca2+ currents in most cultured SPG neurons (34 of
37 tested neurons). A 100-ms voltage step to 0 mV from holding
potential
70 mV evoked a slowly inactivating inward
Ca2+ current, which was largely inhibited in the
presence of 1 µM ACh in the bath solution (Fig.
1A). The inhibition was observed in the
tail current as well (Fig. 1A). The current-voltage (I-V) curve from
60 to +60 mV showed that ACh-induced inhibition occurred at all
voltages (Fig. 1B). In a current versus time plot, which reflects the
real time course of the recording, the inhibition of the
Ca2+ currents by ACh was fast, concentration
dependent, and atropine reversible (Fig. 1C). The
concentration-response curve shows that the maximal inhibition is
63.1 ± 5.6% with EC50 values of 2.8 (1.1-7.2) µM (Fig. 1D).
|
|
Effects of Cholinergic Agents on NO-Mediated Neurogenic
Vasodilation in Porcine Basilar Arteries.
Porcine basilar arterial
rings denuded of endothelial cells in the presence of active muscle
tone induced by U-46619 exclusively relaxed upon TNS at 2 Hz (Fig.
3A). The TNS-elicited vasodilation was
significantly enhanced by 0.1 µM atropine. The enhanced vasodilation was completely inhibited by 30 µM L-NNA and reversed by
L-arginine. The LNNA- and TTX-sensitive TNS-elicited
neurogenic vasodilation, however, was inhibited by exogenous 1 µM ACh
and 1 µM ABET, a muscarinic M2-receptor agonist
(Fig. 3B). These results were reproducible in the basilar arteries from
20 pigs and were consistent with results reported previously (Liu and
Lee, 1999
).
|
Comparable Effects of Preferential Muscarinic M1 and
M2 Agonists on Ca2+ Channel Currents in Rat SPG
Neurons and Porcine Cerebral Neurogenic Vasodilation.
In porcine
basilar arteries, ABET significantly inhibited TNS (2 Hz)-elicited
neurogenic vasodilation, with EC50 values of 0.5 (0.1-2.5) µM and maximal inhibition of 52.2 ± 11.0%
(n = 6; Fig. 4A). On the
other hand, McN-A-343, a preferential muscarinic M1-receptor agonist, inhibited TNS (2 Hz)-elicited neurogenic vasodilation with lower efficacy (maximal
inhibition was 36.0 ± 12.5%; n = 6) and
significantly higher EC50 values (>10 µM) (Fig. 4A).
|
Colocalization of Muscarinic M2 Receptors and N-Type
Ca2+ Channels in the Rat SPG Neurons.
Results from
double-labeling immunocytochemical study indicated that the cultured
rat SPG neurons (1-3 weeks) were immunoreactive for both N-type
Ca2+ channels and muscarinic
M2 receptor (Fig.
5, A and B). The N-type Ca2+ channel immunoreactivity was labeled with
fluorescein isothiocyanate (A) and muscarinic
M2-receptor immunoreactivity with rhodamine (B).
Both N-type Ca2+ channel- and muscarinic
M2-receptor immunoreactive fibers including soma
and dendrites were completely coincident. In negative control, neurons
were not immunoreactive to the antigen preabsorbed N-type Ca2+ channel antibodies or muscarinic
M2-receptor antibodies (data not shown).
|
Effect of CTX on Muscarinic Inhibition of Ca2+ Channel
Currents in the Rat SPG Neurons.
Previous pharmacology studies
demonstrated that TNS-elicited neurogenic vasodilation in porcine
basilar arteries was significantly inhibited by 0.1 µM
-conotoxin,
a selective N-type Ca2+ channel blocker. In the
presence of the inhibition produced by CTX, the residual vasodilation
was not further inhibited by ABET or enhanced by atropine (Liu and Lee,
1999
). Consistent with this report, 1 µM
-conotoxin, but not 0.1 mM nifedipine (a selective L-type Ca2+ channel
blocker), largely inhibited Ca2+ currents in SPG
neurons. In the presence of 1 µM
-conotoxin, the residual
Ca2+ current was not affected by 10 µM ACh or
10 µM ABET (Fig. 6, A and B,
n = 4).
|
Effect of 8-Bromo-cAMP on Muscarinic Inhibition of Ca2+
Channel Currents in the Rat SPG Neurons.
Because muscarinic
M2-receptor-mediated effects often are coupled to
a decrease in intracellular cAMP, 8-bromo-cAMP, a membrane permeable
cAMP analog, was used to examine the involvement of cAMP in the
muscarinic inhibition of Ca2+ channels. In
cultured rat SPG neurons, 1 to 10 mM 8-bromo-cAMP did not affect the
peak Ca2+ currents (n = 3, data
not shown), nor did it affect ACh-induced inhibition of
Ca2+ currents, which, however, were reversed by
atropine (n = 6, Fig. 7).
|
Effect of Pertussis Toxin (PTX) on Muscarinic Inhibition of
Ca2+ Channel Currents in the Rat SPG Neurons.
Because
muscarinic M2 receptors are coupled to
Gi/o protein, PTX, which uncouples
Gi/o protein from receptors by ADP ribosylation (West et al., 1985
), was used to examine the involvement of G proteins
in inhibition of Ca2+ currents in the SPG
neurons. PTX (1 µg/ml) was added to the cell culture dish 24 to
36 h before patch-clamp recording. High concentration (10 µM) of
ACh was used to produce the maximal inhibition of
Ca2+ currents. In control SPG neurons
(n = 8), the maximal inhibition produced by ACh was
64.5 ± 5.8%. In PTX-pretreated SPG neurons (n = 9), the maximal inhibition however was 19.4 ± 16.4%
(n = 9). The difference of the maximal inhibition of
Ca2+ currents between the PTX-treated and
untreated neuron was significant (p < 0.01; Fig.
8).
|
Effect of GTP
S on Muscarinic Inhibition of Ca2+
Channel Currents in the Rat SPG Neurons.
To further investigate
the involvement of G protein in M-receptor-mediated inhibition of
Ca2+ currents in the SPG neurons, GTP
S was
used to replace GTP in the intracellular recording solution in some
studies. GTP
S, a nonhydrolyzable GTP analog, binds tightly to the
-subunit of G proteins and confers a receptor-independent,
irreversible G protein action. When GTP
S was present in the
intracellular solution, the Ca2+ currents in all
recorded SPG neurons were rapidly depressed without adding muscarinic
agonist. After 10 min of dialysis, the residual current was 28.3 ± 5.5% of the original current, and no further inhibition induced by
ACh was observed in the majority of the neurons examined (seven of
nine) (Fig. 9, A and B). The inhibition of Ca2+ currents produced by 10 µM ACh in two
neurons was small and was not reversed by atropine (data not shown).
|
| |
Discussion |
|---|
|
|
|---|
Atropine has been shown to increase NO-mediated cerebral
neurogenic vasodilation in several species including the pig (Liu and
Lee, 1999
), cow (Ayajiki et al., 1993
), and monkey (Toda et al., 1997
).
This effect of atropine has been suggested to be caused by blockade of
presynaptic muscarinic receptors, thereby blocking the inhibitory
effect of endogenously released ACh on NO release (Ayajiki et al.,
1993
; Liu and Lee, 1999
) from perivascular cholinergic-nitrergic nerves
(Kimura et al., 1997
; Yu et al., 1998
). Our results found in porcine
cerebral arteries further suggested that the inhibitory effect of ACh
was mediated by presynaptic M2 receptors, which were coupled to suppression of N-type Ca2+
channels (Liu and Lee, 1999
). In the present study, we further demonstrated that ACh and ABET (a muscarinic
M2-receptor agonist) inhibited NO-mediated
neurogenic vasodilation in porcine cerebral arterial rings and provided
new evidence that these two muscarinic agonists inhibited N-type
Ca2+ currents in the rat SPG neurons, which are
partial sources of cerebrovascular nitrergic nerves. These similar
results found in the pig and rat support our hypothesis that ACh
inhibits neurogenic vasodilation by suppressing
Ca2+ influx through N-type
Ca2+ channels on nitrergic nerves, thereby
causing decreased formation and release of NO and diminished
vasodilation (Fig 10).
|
Muscarinic Inhibition of Neurogenic Vasodilation in Cerebral
Arteries.
Electrical stimulations of perivascular nerves
exclusively cause vasodilation in the large cerebral arteries at the
base of the brain of several species including the pig (Lee, 1994
). The vasodilation is mediated mainly by NO (Lee, 1994
; Zhang et al., 1998
).
In our previous and the present studies, the increase in neurogenic
vasodilation by atropine was completely abolished by L-NNA,
an NOS inhibitor, and fully recovered by further application of
L-arginine, the precursor of NO synthesis. Because atropine did not affect the vasodilation produced by sodium nitroprusside, an NO
donor (data not shown), the enhancement of neurogenic vasodilation induced by atropine was most likely attributable to its presynaptic inhibition of muscarinic receptors resulting in increased NO release. That is, atropine antagonizes the tonic inhibition by endogenous ACh of
NO release (Ayajiki et al., 1993
; Liu and Lee, 1999
) because both ACh
and NO are co-released in the perivascular cholinergic-nitrergic nerves
(Kimura et al., 1997
; Yu et al., 1998
). Further pharmacological and
immunocytochemical studies have shown that the muscarinic M2 receptor is the specific subtype located on
the nitrergic nerves mediating the inhibition of neurogenic
vasodilation induced by ACh in porcine cerebral arteries (Liu and Lee,
1999
). This is further supported by results of the present study.
-Conotoxin, which is a selective blocker of neuronal N-type
Ca2+ channels, largely inhibits NO-mediated
neurogenic vasodilation. This result suggests that
Ca2+ influx through the N-type
Ca2+ channels is important for activation of NOS,
thereby leading to the synthesis and release of NO from the nitrergic
nerves (Boeckxstaens et al., 1993
-conotoxin partially inhibited NO-mediated neurogenic
vasodilation (Liu and Lee, 1999
-conotoxin-insensitive part of neurogenic vasodilation was not
affected by either ACh or ABET, nor was it enhanced by atropine (Liu
and Lee, 1999Muscarinic M2 Receptors Mediate Inhibition of N-Type
Ca2+ Channels in Cultured Rat SPG Neurons.
Due to
difficulties of using patch clamp on the perivascular nerves, the
effects of muscarinic receptor activation or inhibition on
voltage-dependent Ca2+ channels were investigated
in cultured SPG neurons. The SPG is one of the major sources of
cerebral perivascular nitrergic nerves in the rat, cat, and pig (Suzuki
and Hardebo, 1993
; Kimura et al., 1997
; Yu et al., 1998
). SPG neurons
were obtained from adult rats instead of pigs because of inconsistency
in porcine SPG neuronal culture. Cultured rat SPG neurons have been
found to contain neurotransmitters and N-type
Ca2+ channels like those found in cerebral
perivascular nitrergic nerves in whole-mount preparations from the pig
(Liu et al., 2000
).
Possible Mechanisms of Muscarinic Inhibition of Ca2+
Channel Currents in the Rat SPG Neurons.
Although activation of
muscarinic M2 receptor is coupled to an
inhibition of adenylate cyclase (Ui, 1984
; Peralta et al., 1988
), a
decrease in intracellular cAMP level was not a major factor causing
inhibition of cerebral neurogenic vasodilation (Liu and Lee, 1999
).
This was supported by the present findings that 8-bromo-cAMP did not
affect calcium currents, suggesting that cAMP was not the mediator for
the muscarinic inhibition of Ca2+ channel current
in the SPG neurons. This result is consistent with reports by others
that intracellular cAMP is not involved in muscarinic receptor-mediated
inhibition of Ca2+ channels (Anwyl, 1991
; Dolphin
et al., 1991
; Allen and Brown, 1993
; Jeong and Wurster, 1997
), although
an unidentified second messenger has been reported to partially mediate
the muscarinic inhibition of Ca2+ channels in the
superior cervical ganglionic neurons (Bernheim et al., 1991
; Hille,
1992
).
S, was used to interrupt muscarinic
M2-receptor-mediated inhibitory effects. In
tissue bath study, GTP
S failed to affect muscarinic
M2-receptor-mediated inhibition of cerebral
neurogenic vasodilation, possibly because it is membrane impermeable
(Liu and Lee, 1999
S in the intracellular recording solution
caused an inhibition of peak Ca2+ channel
currents, and in the presence of GTP
S, ACh at concentration up to 10 µM failed to cause any effect on the remaining
Ca2+ currents. This result suggests that
muscarinic M2-receptor-mediated inhibition of
Ca2+ channel current was likely to be a Gi
protein-mediated effect; a result similar to those found in other
neurons (Wanke et al., 1987| |
Acknowledgments |
|---|
We thank Jean Long for preparing the manuscript.
| |
Footnotes |
|---|
Accepted for publication March 11, 2002.
Received for publication February 12, 2002.
This work was supported by National Institutes of Health Grants HL 27763 and HL 47574, AHA/IHA (9807871), and SIU-CRC/EAM (to T.J.-F.L.) and R29NS34564 (to M.S.E.).
Address correspondence to: Dr. Tony J.-F. Lee, Department of Pharmacology, Southern Illinois University, School of Medicine, P.O. Box 19629, Springfield, IL 62794-9629. E-mail: tlee{at}siumed.edu
| |
Abbreviations |
|---|
ACh, acetylcholine;
SPG, sphenopalatine
ganglion;
L-NNA, nitro-L-arginine;
TTX, tetrodotoxin;
GTP
S, guanosine
5'-O-(3-thio)triphosphate;
ABET, arecaidine but-2-ynyl
ester tosylate;
4-DAMP, 4-diphenylacetoxy-N-methylpiperidine;
CTX,
-conotoxin;
8-bromo-cAMP, 8-bromoadenosine 3',5'-cyclic
monophosphate;
NO, nitric oxide;
NOS, nitric-oxide synthase;
PBS, phosphate-buffered saline;
MOPS, 3-[N-morpholino]propane-sulfonic acid;
PTX, pertussis
toxin;
U-46619, 9,11-dideoxy-9
,11
-epoxymethanoprostaglandin
F2
;
MR16728, (N-(N'-hexamethylene-imino)-propyl-phenyl-cyclohexyl-methyl
acetamide;
TNS, transmural nerve stimulation.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Toda, K. Ayajiki, and T. Okamura Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Jadhav, A. Jabre, M.-F. Chen, and T. J.-F. Lee Presynaptic Prostaglandin E2 EP1-Receptor Facilitation of Cerebral Nitrergic Neurogenic Vasodilation Stroke, January 1, 2009; 40(1): 261 - 269. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||